| 1 |
Brida M, Chessa M, Celermajer D, et al. Atrial septal defect in adulthood: a new paradigm for congenital heart disease [J]. Eur Heart J, 2022, 43(28): 2660-2671.
|
| 2 |
Burns T, Yang Y, Hiriart E, et al. The dorsal mesenchymal protrusion and the pathogenesis of atrioventricular septal defects [J]. J Cardiovasc Dev Dis, 2016, 3(4): 29.
|
| 3 |
Magnan RA, Kang L, Degenhardt KR, et al. Molecular pathways and animal models of atrial septal defect [J]. Adv Exp Med Biol, 2024, 1441: 481-493.
|
| 4 |
Russell MW, Chung WK, Kaltman JR, et al. Advances in the understanding of the genetic determinants of congenital heart disease and their impact on clinical outcomes [J]. J Am Heart Assoc, 2018, 7(6): e006906.
|
| 5 |
Diab N S, Barish S, Dong W, et al. Molecular genetics and complex inheritance of congenital heart disease [J]. Genes (Basel), 2021, 12(7): 1020.
|
| 6 |
Pierpont ME, Brueckner M, Chung WK, et al. Genetic basis for congenital heart disease: revisited: a scientific statement from the American heart association [J]. Circulation, 2018, 138(21): e653-e711.
|
| 7 |
Zhang X, Qi M, Fu Q. Molecular genetics of congenital heart disease [J]. Sci China Life Sci, 2025, 68(8): 2225-2242.
|
| 8 |
Duarte VE, Singh MN. Genetic syndromes associated with congenital heart disease [J]. Heart, 2024, 110(20): 1231-1237.
|
| 9 |
Zhang H, Liu L, Tian J. Molecular mechanisms of congenital heart disease in down syndrome [J]. Genes Dis, 2019, 6(4): 372-377.
|
| 10 |
Feldman ER, Li Y, Cutler DJ, et al. Genome-wide association studies of down syndrome associated congenital heart defects suggests a genetically heterogeneous risk for CHD in DS [J]. Genet Epidemiol, 2025, 49(4): e70010.
|
| 11 |
Springett A, Wellesley D, Greenlees R, et al. Congenital anomalies associated with trisomy 18 or trisomy 13: a registry-based study in 16 European countries, 2000-2011 [J]. Am J Med Genet A, 2015, 167A(12): 3062-3069.
|
| 12 |
Kosiv KA, Gossett JM, Bai S, et al. Congenital heart surgery on in-hospital mortality in trisomy 13 and 18 [J]. Pediatrics, 2017, 140(5): e20170772.
|
| 13 |
Gravholt CH, Andersen NH, Christin-Maitre S, et al. Clinical practice guidelines for the care of girls and women with Turner syndrome [J]. Eur J Endocrinol, 2024, 190(6): G53-G151.
|
| 14 |
Moran R, Robin NH. Congenital heart defects [M]//Pyeritz RE, Korf BR, Grody WW, eds. Emery and Rimoin's principles and practice of medical genetics and genomics. Philadelphia: Elsevier, 2020: 3-75.
|
| 15 |
Zaidi S, Brueckner M. Genetics and genomics of congenital heart disease [J]. Circ Res, 2017, 120(6): 923-940.
|
| 16 |
Hou HT, Chen HX, Wang XL, et al. Genetic characterisation of 22q11.2 variations and prevalence in patients with congenital heart disease [J]. Arch Dis Child, 2020, 105(4): 367-374.
|
| 17 |
Garg V, Yamagishi C, Hu T, et al. Tbx1, a DiGeorge syndrome candidate gene, is regulated by sonic hedgehog during pharyngeal arch development [J]. Dev Biol, 2001, 235(1): 62-73.
|
| 18 |
Keyte A, Hutson MR. The neural crest in cardiac congenital anomalies [J]. Differentiation, 2012, 84(1): 25-40.
|
| 19 |
Mary L, Lavillaureix A, Perrot A, et al. Prenatal phenotype of 22q11 micro-duplications: a systematic review and report on 12 new cases [J]. Eur J Med Genet, 2022, 65(2): 104422.
|
| 20 |
Ehrlich L, Prakash SK. Copy-number variation in congenital heart disease [J]. Curr Opin Genet Dev, 2022, 77: 101986.
|
| 21 |
Soemedi R, Topf A, Wilson IJ, et al. Phenotype-specific effect of chromosome 1q21.1 rearrangements and GJA5 duplications in 2436 congenital heart disease patients and 6760 controls [J]. Hum Mol Genet, 2012, 21(7): 1513-1520.
|
| 22 |
Liu N, Liu Z, Yi S, et al. Prenatally diagnosed chromosome 1p36 deletions: a retrospective case series, literature review, and genotype-phenotype correlations [J]. BMC Med Genomics, 2025, 19(1): 6.
|
| 23 |
Lalani SR. Other genomic disorders and congenital heart disease [J]. Am J Med Genet C Semin Med Genet, 2020, 184(1): 107-115.
|
| 24 |
Digilio MC, Dentici ML, Loddo S, et al. Congenital heart defects in the recurrent 2q13 deletion syndrome [J]. Eur J Med Genet, 2022, 65(1): 104381.
|
| 25 |
Hills C, Moller JH, Finkelstein M, et al. Cri du chat syndrome and congenital heart disease: a review of previously reported cases and presentation of an additional 21 cases from the Pediatric Cardiac Care Consortium [J]. Pediatrics, 2006, 117(5): e924-927.
|
| 26 |
Nees SN, Chung WK. Genetic basis of human congenital heart disease [J]. Cold Spring Harb Perspect Biol, 2020, 12(9): a036749.
|
| 27 |
Maddhesiya J, Mohapatra B. Understanding the genetic and non-genetic interconnections in the aetiology of syndromic congenital heart disease: an updated review: part 2 [J]. Curr Cardiol Rep, 2024, 26(3): 167-178.
|
| 28 |
Kronquist EK, Kaur M, Gober LM, et al. Airflow obstruction in adults with Williams syndrome and mice with elastin insufficiency [J]. Diagnostics (Basel), 2022, 12(6): 1438.
|
| 29 |
Yuan SM. Congenital heart defects in Williams syndrome [J]. Turk J Pediatr, 2017, 59(3): 225-232.
|
| 30 |
Longoni M, Lage K, Russell MK, et al. Congenital diaphragmatic hernia interval on chromosome 8p23.1 characterized by genetics and protein interaction networks [J]. Am J Med Genet A, 2012, 158A(12): 3148-3158.
|
| 31 |
Barber JC, Rosenfeld JA, Graham JM, et al. Inside the 8p23.1 duplication syndrome; eight microduplications of likely or uncertain clinical significance [J]. Am J Med Genet A, 2015, 167A(9): 2052-2064.
|
| 32 |
Yatsenko SA, Brundage EK, Roney EK, et al. Molecular mechanisms for subtelomeric rearrangements associated with the 9q34.3 microdeletion syndrome [J]. Hum Mol Genet, 2009, 18(11): 1924-1936.
|
| 33 |
Xie H, He P, Sheng Q, et al. Highlighting cardiovascular manifestations of kleefstra syndrome: literature review and clinical insights [J]. BMC Cardiovasc Disord, 2025, 25(1): 175.
|
| 34 |
Fifirig C I, Abraham S, Keavney B, et al. Congenital heart disease presentations in the 15q11.2 microdeletion syndrome [J]. Front Genet, 2025, 16: 1535732.
|
| 35 |
Sanchez P, Farkhondeh A, Pavlinov I, et al. Therapeutics development for Alagille syndrome [J]. Front Pharmacol, 2021, 12: 704586.
|
| 36 |
Bhagia G, Hussain N, Arty F, et al. Parachute mitral valve and mid-aortic syndrome -unusual associations of Alagille syndrome [J]. Eur J Case Rep Intern Med, 2024, 11(6): 004545.
|
| 37 |
Lee C L, Chuang C K, Chen MR, et al. Illuminating the genetic basis of congenital heart disease in patients with Kabuki syndrome [J]. Diagnostics (Basel), 2024, 14(8): 846.
|
| 38 |
Serrano MLA, Demarest BL, Tone-Pah-Hote T, et al. Inhibition of Notch signaling rescues cardiovascular development in Kabuki syndrome [J]. PLoS Biol, 2019, 17(9): e3000087.
|
| 39 |
Zbeidy R, Torres Buendia N, Souki FG. Anaesthetic management of a parturient with spondylothoracic dysostosis [J]. BMJ Case Rep, 2020, 13(1): e232964.
|
| 40 |
Moller Nielsen AK, Dehn AM, Hjortdal V, et al. TBX5 variants and cardiac phenotype: A systematic review of the literature and a novel variant [J]. Eur J Med Genet, 2024, 68: 104920.
|
| 41 |
Vanlerberghe C, Jourdain AS, Ghoumid J, et al. Holt-Oram syndrome: clinical and molecular description of 78 patients with TBX5 variants [J]. Eur J Hum Genet, 2019, 27(3): 360-368.
|
| 42 |
Tompson SW, Ruiz-Perez VL, Blair HJ, et al. Sequencing EVC and EVC2 identifies mutations in two-thirds of Ellis-van Creveld syndrome patients [J]. Hum Genet, 2007, 120(5): 663-670.
|
| 43 |
Aubert-Mucca M, Huber C, Baujat G, et al. Ellis-van Creveld syndrome: clinical and molecular analysis of 50 individuals [J]. J Med Genet, 2023, 60(4): 337-345.
|
| 44 |
Meisner JK, Martin DM. Congenital heart defects in CHARGE: The molecular role of CHD7 and effects on cardiac phenotype and clinical outcomes [J]. Am J Med Genet C Semin Med Genet, 2020, 184(1): 81-89.
|
| 45 |
Stathopoulou A, Wang P, Thellier C, et al. CHARGE syndrome-associated CHD7 acts at ISL1-regulated enhancers to modulate second heart field gene expression [J]. Cardiovasc Res, 2023, 119(11): 2089-2105.
|
| 46 |
van Ravenswaaij-Arts C, Martin DM. New insights and advances in CHARGE syndrome: diagnosis, etiologies, treatments, and research discoveries [J]. Am J Med Genet C Semin Med Genet, 2017, 175(4): 397-406.
|
| 47 |
Williams K, Carson J, Lo C. Genetics of congenital heart disease [J]. Biomolecules, 2019, 9(12): 879.
|
| 48 |
Sifrim A, Hitz MP, Wilsdon A, et al. Distinct genetic architectures for syndromic and nonsyndromic congenital heart defects identified by exome sequencing [J]. Nat Genet, 2016, 48(9): 1060-1065.
|
| 49 |
Garg K, Trehan S, Fredrick F, et al. RASopathies and cardiac complications: insights into mechanisms, diagnosis, and innovative treatments [J]. Curr Cardiol Rev, 2025, 21(6): e1573403X1341624.
|
| 50 |
Feng B, Li X, Zhang Q, et al. Molecular and phenotypic spectrum of cardio-facio-cutaneous syndrome in Chinese patients [J]. Orphanet J Rare Dis, 2023, 18(1): 284.
|
| 51 |
Lin AE, Alexander ME, Colan SD, et al. Clinical, pathological, and molecular analyses of cardiovascular abnormalities in Costello syndrome: a Ras/MAPK pathway syndrome [J]. Am J Med Genet A, 2011, 155A(3): 486-507.
|
| 52 |
Pierpont ME, Magoulas PL, Adi S, et al. Cardio-facio-cutaneous syndrome: clinical features, diagnosis, and management guidelines [J]. Pediatrics, 2014, 134(4): e1149-1162.
|
| 53 |
Li Y, Du J, Deng S, et al. The molecular mechanisms of cardiac development and related diseases [J]. Signal Transduct Target Ther, 2024, 9(1): 368.
|
| 54 |
Eckerström F, Nyboe C, Maagaard M, et al. Survival of patients with congenital ventricular septal defect [J]. Eur Heart J, 2023, 44(1): 54-61.
|
| 55 |
Wang W, Niu Z, Wang Y, et al. Comparative transcriptome analysis of atrial septal defect identifies dysregulated genes during heart septum morphogenesis [J]. Gene, 2016, 575(2 Pt 1): 303-312.
|
| 56 |
Molkentin JD. The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression [J]. J Biol Chem, 2000, 275(50): 38949-38952.
|
| 57 |
Cervantes-Salazar JL, Perez-Hernandez N, Calderon-Colmenero J, et al. Genetic Insights into congenital cardiac septal defects-a narrative review [J]. Biology (Basel), 2024, 13(11): 911.
|
| 58 |
Fan D, Pang S, Chen J, et al. Identification and functional study of GATA4 gene regulatory variants in atrial septal defects [J]. BMC Cardiovasc Disord, 2021, 21(1): 321.
|
| 59 |
Kirk EP, Sunde M, Costa MW, et al. Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy [J]. Am J Hum Genet, 2007, 81(2): 280-291.
|
| 60 |
Huang RT, Wang J, Xue S, et al. TBX20 loss-of-function mutation responsible for familial tetralogy of Fallot or sporadic persistent truncus arteriosus [J]. Int J Med Sci, 2017, 14(4): 323-332.
|
| 61 |
Starkovich M, Lalani SR, Mercer CL, et al. Chromosome 5q33 deletions associated with congenital heart defects [J]. Am J Med Genet A, 2016, 170(12): 3338-3342.
|
| 62 |
Ahmad Rafie NN, Yubbu P, Aissvarya S, et al. Genetic aspects of congenital heart disease in heterotaxy syndrome [J]. Rev Port Cardiol, 2025, 44(10): 633-648.
|
| 63 |
Stanley KJ, Kalbfleisch KJ, Moran OM, et al. Expanding the phenotypic spectrum of NOTCH1 variants: clinical manifestations in families with congenital heart disease [J]. Eur J Hum Genet, 2024, 32(7): 795-803.
|
| 64 |
Jeffries L, Mis EK, McWalter K, et al. Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections [J]. Genet Med, 2024, 26(2): 101023.
|
| 65 |
Quintanilla Anfinson M, Creighton S, Simpson PM, et al. MYH6 variants are associated with atrial dysfunction in neonates with hypoplastic left heart syndrome [J]. Genes (Basel), 2024, 15(11): 1449.
|
| 66 |
Posch MG, Waldmuller S, Muller M, et al. Cardiac alpha-myosin (MYH6) is the predominant sarcomeric disease gene for familial atrial septal defects [J]. PLoS One, 2011, 6(12): e28872.
|
| 67 |
Chong JX, Childers MC, Marvin CT, et al. Variants in ACTC1 underlie distal arthrogryposis accompanied by congenital heart defects [J]. HGG Adv, 2023, 4(3): 100213.
|
| 68 |
Chhatwal K, Smith JJ, Bola H, et al. Uncovering the genetic basis of congenital heart disease: recent advancements and implications for clinical management [J]. CJC Pediatr Congenit Heart Dis, 2023, 2(6Part B): 464-480.
|
| 69 |
Bruneau BG. The developmental genetics of congenital heart disease [J]. Nature, 2008, 451(7181): 943-948.
|
| 70 |
Cao Y, Guo J, Zhang J, et al. HYDIN loss-of-function inhibits GATA4 expression and enhances atrial septal defect risk [J]. Mech Dev, 2020, 162: 103611.
|
| 71 |
Rao E, Annavarapu S. Genetics of congenital heart disease: a narrative review of challenges and strategies in identifying novel genes [J]. Cureus, 2025, 17(9): e91674.
|
| 72 |
Chen Z, Chen HX, Hou HT, et al. Genetic variants of CITED2 gene promoter in human atrial septal defects: case-control study and cellular functional verification [J]. J Cardiovasc Dev Dis, 2022, 9(10): 321.
|